.On the heels of an FDA denial for its main rivalrous Novo Nordisk, Eli Lilly is actually pulling ah...
.Just a few months after dosing the initial client in a phase 2 trial for newly detected glioblastom...
.Eli Lilly's look for being overweight targets has led it to the darker genome. The Big Pharma has a...
.Toolbox Biosciences is actually carrying on up. The tissue therapy provider has added $325 thousand...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...
.Aelis Farma's hopes of getting a simple, beneficial decision on a $100 million alternative remittan...
.ProKidney has ceased some of a pair of stage 3 tests for its cell treatment for renal disease after...
.Vaxcyte revealed what analysts referred to as "magnificent" phase 1/2 records for its 31-valent pne...
.Recursion has actually discovered through a very early examination of its tech-enabled strategy to ...
.Call it a situation of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning scientif...